Molina Healthcare (NYSE:MOH) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Key Points

• Molina Healthcare beat quarterly earnings expectations, reporting $0.89 in EPS versus the $0.79 consensus estimate. Revenue totaled $11.08 billion, ahead of analysts’ $10.86 billion forecast.
• Shares fell $4.93 to $214.79 during Wednesday trading. Molina has a $11.21 billion market capitalization and traded between $121.06 and $244.89 over the past year.
• Analyst sentiment remains cautious, with a consensus “Hold” rating from 17 analysts and an average price target of $202.44; ratings include three Buys, 12 Holds and two Sells.

Molina Healthcare (NYSE:MOH - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.89 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.10, FiscalAI reports. The company had revenue of $11.08 billion for the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%.

Molina Healthcare Price Performance

NYSE:MOH traded down $4.93 during mid-day trading on Wednesday, reaching $214.79. The stock had a trading volume of 1,172,663 shares, compared to its average volume of 1,283,433. The stock has a market capitalization of $11.21 billion, a P/E ratio of -1,193.21, a P/E/G ratio of 30.14 and a beta of 0.78. The firm has a 50 day moving average price of $200.31 and a two-hundred day moving average price of $194.98. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. Molina Healthcare has a one year low of $121.06 and a one year high of $244.89.

Analyst Ratings Changes

MOH has been the subject of several research analyst reports. TD Cowen lifted their target price on shares of Molina Healthcare from $163.00 to $230.00 and gave the company a "hold" rating in a research report on Tuesday, July 14th. Cantor Fitzgerald reissued a "neutral" rating on shares of Molina Healthcare in a report on Friday, October 9th. Zacks Research lowered shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Monday, October 12th. Barclays lowered their price objective on shares of Molina Healthcare from $184.00 to $180.00 and set an "underweight" rating on the stock in a research report on Friday, July 24th. Finally, Sanford C. Bernstein set a $286.00 price objective on shares of Molina Healthcare in a report on Monday, July 13th. Three analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $202.44.

About Molina Healthcare

Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.

The company's services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.